Rani Therapeutics Holdings, Inc.
RANI institutional ownership changes in Q2 2026: 15 institutions opened or added positions, 21 trimmed or exited. RANI (Rani Therapeutics Holdings, Inc.) is held by 39 institutional investors as of Q2 2026. Top institutional shareholders: RA Capital Management, L.P. ($6.5M), Vanguard Capital Management LLC ($3.5M), Geode Capital Management, LLC ($677,575). Institutions were selling, on balance.
Who's Trading
Latest move
Source dates: Price Nov 6, 2026 · Insiders Sep 29, 2026 · Activists Aug 14, 2026 · Congress none
Top Holders
| Action | ||||||
|---|---|---|---|---|---|---|
Unchanged | 8.5M | $6.5M | 0.1% | -58.81% | 0 | |
Decreased | 4.6M(-1.3%) | $3.5M | 0.0% | -24.35% | 0 | |
Decreased | 890,618(-1.4%) | $677,575 | 0.0% | -79.49% | 0 | |
New | 641,995 | $488,173 | 0.0% | -26.84% | 33 | |
New | 586,265 | $445,561 | 0.0% | -26.84% | 33 | |
Increased | 485,899(+193.4%) | $369,478 | 0.0% | -26.01% | 26 | |
Increased | 458,126(+0.7%) | $348,176 | 0.0% | -24.37% | 24 | |
New | 430,737 | $327,532 | 0.0% | -26.84% | 33 | |
Unchanged | 373,142 | $283,737 | 0.0% | -77.90% | 0 | |
Decreased | 342,113(-38.6%) | $260,142 | 0.0% | -58.04% | 0 | |
Increased | 297,270(+30.8%) | $225,926 | 0.0% | -47.90% | 20 | |
Unchanged | 170,471 | $129,626 | 0.0% | -82.31% | 0 | |
Unchanged | 58,000 | $44,103 | 0.0% | -78.14% | 0 | |
Decreased | 57,790(-69.3%) | $43,944 | 0.0% | -39.61% | 0 | |
Increased | 41,902(+155.5%) | $31,862 | 0.0% | -43.89% | 22 | |
Unchanged | 31,751 | $24,131 | 0.0% | -24.35% | 0 | |
Increased | 30,486(+25.1%) | $23,182 | 0.0% | -58.50% | 16 | |
Decreased | 20,700(-73.5%) | $15,740 | 0.0% | -58.81% | 0 | |
Unchanged | 19,090 | $14,516 | 0.0% | -62.47% | 0 | |
Increased | 19,051(+81.4%) | $14,486 | 0.0% | -25.49% | 19 |
Showing 1-20 of 47
| Insider | Trade | Traded |
|---|---|---|
| Javadi Alireza | Tax 309 sh | |
| Imran Talat | Tax 8K sh | |
| IMRAN MIR A | Buy $25K | |
| Imran Talat | Buy $25K | |
| Javadi Alireza | Tax 309 sh | |
| Imran Talat | Tax 8K sh | |
| Javadi Alireza | Sell $301.08 | |
| Imran Talat | Tax 9K sh | |
| Imran Talat | Tax 9K sh | |
| Imran Talat | Tax 8K sh |
| Filer | Stake | Filed |
|---|---|---|
| RA Capital Management, L.P. | 9.9% | |
| Vanguard Capital Management | 4.5% | |
| Samsara BioCapital, L.P. | 5.0% | |
| SymBiosis Capital Partners, LLC | 4.4% | |
| Vanguard Capital Management | 5.1% | |
| The Vanguard Group | 0.0% | |
| AWM Investment Company, Inc. | 9.9% | |
| SymBiosis Capital Partners, LLC | 6.5% | |
| RA Capital Management, L.P. | 9.9% | |
| InCube Labs, L.L.C. | 18.7% |
RANIRani Therapeutics Holdings, Inc.Continue exploring
Other Healthcare stocks held by institutions
UNHUnitedHealth Group Incorporated
LLYEli Lilly and Company
TMOThermo Fisher Scientific Inc
JNJJohnson & Johnson
DHRDanaher Corporation
ISRGIntuitive Surgical, Inc.
MRKMerck & Company, Inc.
ABBVAbbVie Inc.
BSXBoston Scientific Corporation
ABTAbbott LaboratoriesQuestions investors ask about RANI
Who owns RANI?
39 institutional investors held RANI on June 30, 2026, led by RA Capital Management, L.P. ($6.5M), Vanguard Capital Management LLC ($3.5M) and Geode Capital Management, LLC ($677,575).
How many hedge funds hold RANI?
39 institutional investors reported RANI in their 13F filings for the quarter ended June 30, 2026, $13.8M in all. 2 of them are rated Elite.
Are institutions buying or selling RANI?
Selling, on balance. In Q2 2026, 21 institutions trimmed or exited RANI and 15 institutions opened or added to positions.
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer